Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2022-06-24 00:00:00 ET · period of report 2022-06-22 · accession 0001209191-22-039295 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-24 | 2022-06-22 | KYNB | Wettig Thane | Chief Commercial Off | F - Tax | $11.42 | -655 | 91.3K | -0.7% | -$7,480 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-22 | F | D | 655 | $11.42 | 91,294 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. (F2) Includes 1,988 shares acquired on May 13, 2022 through the Issuer's Employee Stock Purchase Plan. |